We currently do not have sufficient information about the CEO.
Key information
Noel Doheny
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
14.4yrs
CEO ownership
n/a
Management average tenure
no data
Board average tenure
5.3yrs
Recent management updates
Recent updates
CEO
Noel Doheny
14.4yrs
Tenure
Dr. Noel Thomas Doheny has been the Chief Executive Officer of Epigenomics Inc. at Epigenomics AG since May 2011. Dr. Doheny manages all US activities and global business development and partnership develo...
Board Members
Name
Position
Tenure
Compensation
Ownership
Helge Lubenow
Chairman of the Supervisory Board
9.4yrs
€25.00k
no data
Alexander Link
Vice-chairman of Supervisory Board
5.3yrs
€25.00k
no data
Jochen Hummel
Member of Supervisory Board
1.7yrs
no data
no data
5.3yrs
Average Tenure
55yo
Average Age
Experienced Board: EPGN.F's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/10/15 21:25
End of Day Share Price
2025/07/18 00:00
Earnings
2025/06/30
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Epigenomics AG is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.